Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LMACU
2501
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
| $6.75M | ﹤0.01% |
653,057
-46,124
| -7% | -$484K |
|
2502
Kearny Financial
KRNY
$642M
| $6.74M | ﹤0.01% |
542,323
-178,453
| -25% | -$2.2M |
|
2503
Fate Therapeutics
FATE
$292M
| $6.73M | ﹤0.01% |
113,561
-53,973
| -32% | -$4.23M |
|
2504
Coca-Cola Femsa
KOF
$23.6B
| $6.72M | ﹤0.01% |
119,436
-43,583
| -27% | -$2.44M |
|
2505
Aflac
AFL
$58.5B
| $6.72M | ﹤0.01% |
128,846
+53,268
| +70% | +$2.91M |
|
2506
Insperity
NSP
$2.06B
| $6.71M | ﹤0.01% |
60,606
-7,721
| -11% | -$793K |
|
|
EPHY
2507
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
| $6.69M | ﹤0.01% |
684,459
-1,027,300
| -60% | -$9.97M |
|
2508
Relmada Therapeutics
RLMD
$464M
| $6.67M | ﹤0.01% |
254,580
+238,351
| +1,469% | +$6.38M |
|
2509
Murphy Oil
MUR
$5.09B
| $6.67M | ﹤0.01% |
267,095
-24,543
| -8% | -$529K |
|
2510
PUT
Carvana
CVNA
$53.2B
| $6.66M | ﹤0.01% |
110,500
+47,000
| +74% | +$3.13M |
|
|
POSH
2511
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $6.66M | ﹤0.01% |
+280,243
| New | +$8.98M |
|
|
ENIA
2512
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $6.65M | ﹤0.01% |
1,137,364
-60,584
| -5% | -$406K |
|
|
GTPA
2513
DELISTED
Gores Technology Partners, Inc. Class A Common Stock
GTPA
| $6.65M | ﹤0.01% |
677,030
+56,539
| +9% | +$554K |
|
2514
Pricesmart
PSMT
$5.23B
| $6.64M | ﹤0.01% |
85,692
+81,051
| +1,746% | +$6.88M |
|
|
PSTX
2515
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $6.63M | ﹤0.01% |
909,856
-136,267
| -13% | -$1.17M |
|
|
GLS
2516
DELISTED
Gelesis Holdings, Inc.
GLS
| $6.63M | ﹤0.01% |
668,200
+214,778
| +47% | +$2.12M |
|
|
SAGE
2517
DELISTED
Sage Therapeutics
SAGE
| $6.63M | ﹤0.01% |
149,568
+79,583
| +114% | +$3.65M |
|
2518
Sempra
SRE
$54.8B
| $6.62M | ﹤0.01% |
104,616
+74,236
| +244% | +$4.9M |
|
|
KAIRU
2519
DELISTED
Kairos Acquisition Corp. Unit
KAIRU
| $6.6M | ﹤0.01% |
658,000
| – | – |
|
|
AIRC
2520
DELISTED
Apartment Income REIT Corp.
AIRC
| $6.6M | ﹤0.01% |
135,165
+93,262
| +223% | +$4.72M |
|
2521
Grindr
GRND
$2.72B
| $6.6M | ﹤0.01% |
651,087
| – | – |
|
|
X
2522
PUT
DELISTED
US Steel
X
| $6.59M | ﹤0.01% |
300,000
| – | – |
|
2523
TransAlta
TAC
$3.84B
| $6.59M | ﹤0.01% |
623,431
+523,171
| +522% | +$5.24M |
|
|
AGC
2524
DELISTED
Altimeter Growth Corp
AGC
| $6.59M | ﹤0.01% |
644,754
+439,502
| +214% | +$4.69M |
|
2525
STAAR Surgical
STAA
$1.11B
| $6.58M | ﹤0.01% |
51,198
+42,082
| +462% | +$5.89M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.